Guestmaymn perguntado 7 anos
The safety and efficacy of Renagel in CKD patients who are not on dialysis have not been studied. There are many confounding variables, however, and how these factors interact is not yet fully understood. Dronedarone: (Major) In dronedarone clinical trials, bradycardia was seen more frequently in patients also receiving beta blockers. Terazosin may decrease the vasoconstricting activities of Nylidrin. Upon entry into the study, all patients were assigned a new open-label NRTI regimen, which was dependent on their previous NRTI treatment experience. Revision Date: 6/14/2011 11:28:52 AM.